Results 111 to 120 of about 57,670 (308)

Real‐life implementation of guideline‐recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE‐HF

open access: yesEuropean Journal of Heart Failure, EarlyView.
Primary results of TITRATE‐HF. GRMT, guideline‐recommended medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction. Abstract Aims Guideline‐recommended medical therapy (GRMT) improves outcomes in heart failure (HF) with reduced ejection fraction (HFrEF), yet implementation ...
Jishnu Malgie   +15 more
wiley   +1 more source

Intravenous pacemaker lead implantation for a pediatric patient: A 16-year follow-up study

open access: yesJournal of Arrhythmia, 2013
Intravenous pacemaker lead implantation for small children is not performed routinely. Here, we report the case of a pediatric patient who underwent endocardial lead implantation and follow-up for 16 years.
Susumu Nakamoto   +6 more
doaj   +1 more source

Electrocardiographic Diagnosis of Atrial Tachycardia: Classification, P-Wave Morphology, and Differential Diagnosis with Other Supraventricular Tachycardias [PDF]

open access: yes, 2014
Atrial tachycardia is defined as a regular atrial activation from atrial areas with centrifugal spread, caused by enhanced automaticity, triggered activity or microreentry.
Buttà, C   +3 more
core   +1 more source

Impact of comorbidity burden on outcome in patients with cardiogenic shock: A Cardiogenic Shock Working Group analysis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Impact of comorbidity burden on outcome in patients with cardiogenic shock. AMI, acute myocardial infarction; CAD, coronary artery disease; CI, confidence interval; CKD, chronic kidney disease; COMRI‐CS; Comorbidity Risk Index for Cardiogenic Shock; COPD, chronic obstructive pulmonary disease; CS, cardiogenic shock; CSWG, Cardiogenic Shock Working ...
Jonas Sundermeyer   +52 more
wiley   +1 more source

Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC‐HF II molecular substudy

open access: yesEuropean Journal of Heart Failure, EarlyView.
FERRIC‐HF II molecular substudy. FDI, ferric derisomaltose. Aims Skeletal muscle energetic augmentation might be a mechanism via which intravenous iron improves symptoms in heart failure, but no direct measurement of intrinsic mitochondrial function has been performed to support this notion.
Mohamad F. Barakat   +16 more
wiley   +1 more source

A Comparison of Patient History- and EKG-based Cardiac Risk Scores. [PDF]

open access: yes, 2019
Patient-specific risk scores are used to identify individuals at elevated risk for cardiovascular disease. Typically, risk scores are based on patient habits and medical history - age, sex, race, smoking behavior, and prior vital signs and diagnoses.
Miller, Andrew C   +2 more
core  

Deep phenotyping of heart failure with preserved ejection fraction through multi‐omics integration

open access: yesEuropean Journal of Heart Failure, EarlyView.
Deep phenotyping of of heart failure with preserved ejection fraction (HFpEF) through multi‐omics integration. AI, artificial intelligence. Aims Heart failure with preserved ejection fraction (HFpEF) has become the predominant form of heart failure and a leading cause of global cardiovascular morbidity and mortality.
Jakob Versnjak   +15 more
wiley   +1 more source

Beta‐blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes

open access: yesEuropean Journal of Heart Failure, EarlyView.
In total, 5084 patients from Swedish registries with both heart failure (HF) with reduced ejection fraction (HFrEF) and chronic obstructive pulmonary disease (COPD) were included. Confounding was handled by overlap weighting based on propensity scores for beta‐blocker use. Patients were followed up for 5 years, or until death, emigration from Sweden or
Benedikt N. Beer   +17 more
wiley   +1 more source

Effects of semaglutide in obesity‐related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP‐HFpEF programme

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Background The prevalence of heart failure with preserved ejection fraction (HFpEF) increases with age, and older adults with HFpEF have worse physical function, quality of life, and clinical outcomes. Semaglutide demonstrated efficacy in the treatment of obesity‐related HFpEF in the STEP‐HFpEF trials.
Ambarish Pandey   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy